Please login to the form below

Not currently logged in
Email:
Password:

Trulicity

This page shows the latest Trulicity news and features for those working in and with pharma, biotech and healthcare.

Novo bolstered by new diabetes, obesity products

Novo bolstered by new diabetes, obesity products

Despite facing tough competition from its class rivals, particularly first-to-market Trulicity (dulaglutide) from Eli Lilly, Ozempic has continued to be a source of growth for Novo.

Latest news

More from news
Approximately 8 fully matching, plus 36 partially matching documents found.

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Merrill Brink International

Merrill Brink International is a leading provider of life sciences, legal, financial, manufacturing and corporate language solutions for global companies....

Latest intelligence

Pharma index map
The 2019 CPhI Pharma Index Report
Examining this year’s industry performance...
Five key trends in precision and personalised healthcare
Here, we deep dive into five of the key trends in precision medicine and personalised healthcare to explore how the healthcare industry is changing and how pharmaceutical and biotech companies...
OPEN Health Graduate Programme: from OPEN VIE to OPEN Health Medical Communications
Isobel Owens shares her experience of the OPEN Health Graduate Programme from OPEN VIE to OPEN Health Medical Communications...

Infographics